Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ekso Bionics HoldingsEKSO -0.42%32 3-Year ROIIC % is 284.80 as of Dec. 2025, which is 1437% above its 10-year median of 18.53. GuruFocus rates EKSO with a GF Score™ of 32/100 and a GF Value™ of $4.40. The stock has 10 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Ekso Bionics Holdings ranks better than 94.97% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Ekso Bionics Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 284.80%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Ekso Bionics Holdings's 3-Year ROIIC % or its related term are showing as below:
EKSO's 3-Year ROIIC % is ranked better than 94.97% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 1.615
vs EKSO: 284.80
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Ekso Bionics Holdings 3-Year ROIIC % Related Terms
Ekso Bionics Holdings 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Ekso Bionics Holdings's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EKSO vs POCI, HBIO, NEPH: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ekso Bionics Holdings 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Ekso Bionics Holdings's 3-Year ROIIC % falls into.
Ekso Bionics Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -13.326 (Dec. 2025) - -15.556 (Dec. 2022) )
/
( 15.732 (Dec. 2025) - 14.949 (Dec. 2022) )
=
2.23
/
0.783
=
284.80%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Ekso Bionics Holdings (EKSO) has a 3-Year ROIIC % of 284.80 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Ekso Bionics Holdings and its competitors. This is 1437% above median its historical median of 18.53. According to the industry distribution chart, Ekso Bionics Holdings ranks #40 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 5%.
Is Ekso Bionics Holdings' 3-Year ROIIC % too high?
Ekso Bionics Holdings' current 3-Year ROIIC % of 284.80 is 1437% above median its 10-year median of 18.53. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.62. Ekso Bionics Holdings' value of 284.80 is 17534.7% above this industry median. Based on the distribution chart, Ekso Bionics Holdings ranks #40 out of 796 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ekso Bionics Holdings has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Ekso Bionics Holdings' 3-Year ROIIC % compare to POCI and HBIO?
According to the Medical Devices & Instruments industry distribution chart, Ekso Bionics Holdings ranks #40 out of 796 companies for 3-Year ROIIC %. This places Ekso Bionics Holdings in the top 5% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.62. Ekso Bionics Holdings' value of 284.80 is 17534.7% above this benchmark. While the company's 10-year median is 18.53 vs. the industry median of 1.62, Ekso Bionics Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.62, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ekso Bionics Holdings's current 3-Year ROIIC % of 284.80 is 17534.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Ekso Bionics Holdings and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ekso Bionics Holdings's current 3-Year ROIIC % is 284.80, which is 1437% above median its own 10-year median of 18.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ekso Bionics Holdings stock overvalued right now?
Ekso Bionics Holdings (EKSO) has a current 3-Year ROIIC % of 284.80. The stock's GF Value™ is $4.40, compared to a current price of $11.65 — trading 164.8% above its estimated fair value. The current 3-Year ROIIC % is 284.80, which is 1437% above median its 10-year median of 18.53 and 17534.7% above the Medical Devices & Instruments industry median of 1.62. Ekso Bionics Holdings' overall GF Score™ is 32/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Ekso Bionics Holdings (EKSO), the current 3-Year ROIIC % is 284.80 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ekso Bionics Holdings (EKSO) Overvalued in 2026?
Based on GuruFocus' analysis, Ekso Bionics Holdings stock appears to be overvalued.
The current stock price of $11.65 is trading 164.8% above its estimated GF Value™ of $4.40.
Key valuation signals for EKSO:
3-Year ROIIC %: 284.80 (1437% above median its 10-year median of 18.53)
GF Value™: $4.40 vs. price of $11.65 (164.8% above fair value)
Industry Position: 17534.7% above the Medical Devices & Instruments median (#40 of 796)
No single metric tells the full story. See the EKSO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
32GF Score
Get the complete analysis for EKSO
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EKSO has been successfully added to your 
